Many studies have reported elevation of IFN in SLE either measured directly or more often indirectly through elevation of IFN response gene mRNA expression.3 4 Several anti-IFN-specific monoclonal antibodies have been studied in clinical trials to determine their efficacy and safety in SLE. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.